BFC Planning’s Connect Biopharma Holdings CNTB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$440 Hold
400
– – ﹤0.01% 3301
2026
Q2
$952 Hold
400
– – ﹤0.01% 3158
2026
Q1
$1.05K Sell
400
-100
-20% -$261 ﹤0.01% 2735
2025
Q4
$1.41K Hold
500
– – ﹤0.01% 2716
2025
Q3
$755 Buy
+500
New +$885 ﹤0.01% 2683

Other funds holding CNTB

BFC Planning's CNTB Position: Q3 2026 in Review

BFC Planning held its Connect Biopharma Holdings (CNTB) position steady in Q3 2026 at 400 shares worth $440. The position accounts for ﹤0.01% of the portfolio, ranked #3301.

BFC Planning first reported a position in CNTB in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.41K in Q4 2025. 42 funds tracked by Wall St. Rank hold CNTB as of Q3 2026.

  • BFC Planning held 400 shares of Connect Biopharma Holdings worth $440 as of Q3 2026.
  • BFC Planning left its Connect Biopharma Holdings share count unchanged in Q3 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3301 holding.
  • BFC Planning first reported a position in Connect Biopharma Holdings in Q3 2025 and has held it in 5 quarters since.
  • BFC Planning's Connect Biopharma Holdings position peaked at $1.41K in Q4 2025.
  • 42 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.